Clinical Trial Update: Chronic Migraine Treatment With Botulinum Toxin-A: an Investigation of Functional Magnetic Resonance Imaging Changes. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating changes in functional MRI associated with Botulinum Toxin-A treatment for chronic migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: University of Manitoba | Conditions: Chronic Migraine | Phase 4 | Status: COMPLETED